Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05660863 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

StatusNot Yet Recruiting
PhasePhase 1
Started2027-09-01
View on ClinicalTrials.gov ↗
This trial is a single-center, Phase 1, placebo-controlled, double-blind, multiple-dose study in two ascending dose cohorts of healthy subjects. The primary objective of the trial is to assess the safety and tolerability of multiple doses of MN-08 tablet administered for 6.5 consecutive days in healthy subjects.

Amendment history 2 changes detected by DataLookout

2026-09-15
Primary completion pushed: 2026-03-30 → 2028-03-30
2026-09-15
Completion pushed: 2026-06-01 → 2028-06-01
Trial Details
NCT Number NCT05660863
Lead Sponsor Guangzhou Magpie Pharmaceuticals Co., Ltd.
Conditions Pulmonary Arterial Hypertension
Enrollment 16 participants
Start Date 2027-09-01
Primary Completion 2028-03-30 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-14